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Persistent inﬂammation and the generation of reactive oxygen
and nitrogen species play pivotal roles in tissue injury during
disease pathogenesis and as a reaction to toxicant exposures. The
associated oxidative and nitrative stress promote diverse patho-
logic reactions including neurodegenerative disorders, atheroscle-
rosis, chronic inﬂammation, cancer, and premature labor and
stillbirth. These effects occur via sustained inﬂammation, cellular
proliferation and cytotoxicity and via induction of a proangiogenic
environment. For example, exposure to the ubiquitous air
pollutant ozone leads to generation of reactive oxygen and
nitrogen species in lung macrophages that play a key role in
subsequent tissue damage. Similarly, studies indicate that genes
involved in regulating oxidative stress are altered by anesthetic
treatment resulting in brain injury, most notable during de-
velopment. In addition to a role in tissue injury in the brain,
inﬂammation, and oxidative stress are implicated in Parkinson’s
disease, a neurodegenerative disease characterized by the loss of
dopamine neurons. Recent data suggest a mechanistic link
between oxidative stress and elevated levels of 3,4-dihydroxyphe-
nylacetaldehyde, a neurotoxin endogenous to dopamine neurons.
These ﬁndings have signiﬁcant implications for development of
therapeutics and identiﬁcation of novel biomarkers for Parkin-
son’s disease pathogenesis. Oxidative and nitrative stress is also
thought to play a role in creating the proinﬂammatory microen-
vironment associated with the aggressive phenotype of inﬂamma-
tory breast cancer. An understanding of fundamental concepts of
oxidative and nitrative stress can underpin a rational plan
of treatment for diseases and toxicities associated with excessive
production of reactive oxygen and nitrogen species.
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Toxicantscausetissuedamageviadiversemechanisms,many
of which involve activation of cell survival and apoptosis
pathways. One of the key areas of recent interest is the role that
oxidative and nitrative stress play in mediating the response to
toxicants via this cytotoxic pathway. Two broad categories of
apoptosis networks, referred to as the intrinsic and extrinsic
pathways have been identiﬁed (reviewed in Aslan et al., 2008).
Theextrinsicpathwayisdrivenbysignalingfromdeathreceptors
such as the tumor necrosis factor-a (TNF-a) receptor and Fas
(Fig. 1) through the death-inducing signaling complex (DISC)
and caspase 8. The intrinsic pathway is triggered by cellular
stress and signals through survival kinases to the mitochondria
whichthenengagecaspase9throughcytochromecrelease.Both
pathways converge on caspase 8 leading to cellular execution
(reviewed in Aslan et al., 2008). Oxidative and nitrative species
can impact on these pathways at several key points; reactive
nitrogen species (RNS) and reactive oxygen species (ROS) can
modulate survival signaling molecules such as c-Jun N-terminal
kinase and p38 mitogen activated protein (MAP) kinase
(reviewed in Aslan et al., 2008). Similarly RNS such as nitric
oxide (NO) are able to cause DNA damage, leading to p53
stabilization and engagement of apoptosis pathways. Con-
versely, NO downregulates nuclear factor jB (NF-jB) which
protects from apoptosis. This review analyzes the role for
oxidative and nitrosative species in the response to diverse
toxicantsandpresentsevidencefromdifferenttissuestoillustrate
areas of consensus and those where more knowledge is needed.
[The concepts and ideas were presented and debated at the
Symposium ‘Oxidative and Nitrative Stress in Toxicology and
Disease’ held at the annual Society of Toxicology Meeting,
Baltimore, March 16, 2009.]. Although the examples chosen are
deliberately diverse, there is much in common: ‘‘Replication
‘with difference’ builds the best case for a generality – for how
canweproveacoordinatinghypothesisunlesswecanapplyitto
multiple cases’’ (Gould, 2002). In addition, we propose new
targets and therapeutic interventions for treatment of various
disease pathologies.
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Aerobic biologic systems have the capability of oxidizing
some substances and reducing others, the ultimate oxidant
being O2 and reducing species attributed to ‘‘food’’ (Fig. 2).
The term ‘‘oxidative stress’’ is not deﬁned intrinsically but
balance models of oxidant stress based on chemical equilib-
rium concepts are most inﬂuenced by inhale/exhale and feast/
fast effects (Smith, 1991). Lower glutathione (GSH) levels may
reﬂect increased rates of oxidation of GSH, by reduction of
H2O2 or other oxidants (Fig. 2). This would be associated with
increased concentrations of glutathione disulﬁde (GSSG) and
increased rates of production or pool turnover as additional
indicators of increased oxidant activities. Conversely, when
lower GSH levels compromise antioxidant defence functions,
increases in oxidation of the substrate molecules proposed to be
at greater exposure would be expected. Lower GSH concen-
trations may act through increased GSSG/GSH ratios, resulting
in increased S-thiolations of critical protein thiols.
In experimental animals, massive increases in production of
GSSG can be affected without initiation of tissue injury or even
of appreciable decreases in tissue levels of GSH (Gupta et al.,
1994; Smith, 1987). Conversely, much greater decreases in
GSH levels can be produced without increasing production of
GSSG or initiating tissue injury (Smith, 1991). Increases in
GSSG formation can be observed in models in which injury
also is produced, but the association with damage is more
robust with other biomarkers. At the same time, the absence of
measurable changes in cell or tissue levels of GSSG do not
disprove hypotheses regarding oxidant contributions to a mech-
anism of damage or other effect, as compartmentalization of
FIG. 1. A schematic depicting the impact of NO and ROS on the intrinsic
and extrinsic pathways that regulate apoptosis.
FIG. 2. Cellular compartmentation of GSH and GSSG and metabolism of oxidants. Extracellular, intracellular, mitochondrial, and nuclear compartments are
indicated, but other subcompartmental distinctions are not precluded. Although simpliﬁed, the schemes shown illustrate the fractal properties of branching in H2O2
disposition, as between GPx and other thiol/disulﬁde-dependent pathways, and Fe-chelate–directed reactions that are not reﬂected by thiol/disulﬁde reactions. Also
illustrated is that cellular oxidation capacities are based on O2 and reduction capacities ultimately rely upon food, with NADPH as a key intermediary for any
estimates of a global or ‘the’ redox status of a cell. Other concepts to consider are that H2O2 could react with Fe
2þ to form hydroxyl radicals which may lead to
lipid peroxides, but perhaps not directly to LOH. DNA (both nuclear and mitochondrial) may also be a target for such radicals. Abbreviations: CoASH, coenzyme
A; CoASSG, mixed disulﬁde of CoASH with GSH; PSH, protein thiol, PSSG, mixed disulﬁde with GSSG; GPx, glutathione peroxidase; GR, GSSG reductase;
ALF, alveolar lining ﬂuid; LOH and LOOH, lipid hydroxy acids and hydroperoxides, respectively.
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obscure the relevant mechanisms from detection by less
speciﬁc methods of analysis. Changes in concentrations or
ratios of a given thiol/disulﬁde pair, such as GSH/GSSG, or
other redox couple, such as nicotinamide adenine dinucleotide
phosphate (reduced) (NADPH)/nicotinamide adenine dinucle-
otide phosphate (NADPþ) are not necessarily accompanied by
changes in other couples that would be predicted from
chemical principles applicable to homogeneous solutions and
should not be accepted uncritically as evidence of a parallel
effect. Nevertheless, changes in biomarker pairs do offer
evidence that something is different and thereby can provide
useful clues for avenues for further investigation (Smith, 2005).
OXIDATIVE STRESS, MITOCHONDRIAL DYSFUNCTION,
AND BRAIN INJURY
Increasing evidence suggests a role for oxidative and
nitrative stress in potential adverse reactions to anesthetics.
Recent studies using in vitro approaches or in vivo animal
models have indicated that blocking oxidative or nitrative
stress will ameliorate anesthetic-induced brain cell death. The
brain has been highlighted by advances in pediatric and
obstetric surgery, which have necessitated an increase in the
duration and complexity of anesthetic procedures. Speciﬁcally,
it has been reported that anesthetic drugs cause widespread
and dose-dependent apoptosis in the developing rat brain
(Ikonomidou et al., 1999; Jevtovic-Todorovic et al., 2003;
Scallet et al., 2004). In order to understand this phenom-
enon and its relevance to humans, studies have been un-
dertaken in the monkey, a species with marked similarities to
human physiology, pharmacology, metabolism, and reproduc-
tive systems. The window of vulnerability to the neuronal
effects of anesthetics is restricted to the period of rapid
synaptogenesis, also known as the brain growth spurt.
Although the synaptogenesis is largely a early postnatal event
in the rodent (ﬁrst 2 weeks of life), in the human and
nonhuman primate it extends from mid pregnancy through the
ﬁrst 2 years or ﬁrst few months of life in the human and
monkey, respectively.
In comparing the rodent and the nonhuman primate data, it is
clear that the topography, characteristics and neuronal suscep-
tibility to neurotoxic insult that leads to neuronal cell death
depends on several factors including the dose and duration of
exposuretoanesthetic,thereceptorsubtypeactivatedandthecell
type, as well as the animal’s stage of development (Ankarkona
et al., 1995, Slikker et al., 2007; Wang et al., 2000). For one
agent, the noncompetitive NMDA (N-methyl-d-aspartate) re-
ceptor antagonist and dissociative anesthetic, ketamine, the
durationofexposurerequiredtoinducecelldeathunderminimal
exposure requirements is similar (4–6 h) for nonhuman primate
and rodent brain cells in culture. In vivo, the susceptible stage or
period of development has not been completely described but
begins somewhere before the last quarter of pregnancy and
continues to shortly after birth in the nonhuman primate. Shorter
durationketamineexposures(ketamineinfusion3hvs.9or24h)
do not produce neuronal cell death in this model (Slikker et al.,
2007).
Reduction of Oxidative Stress Protects from Cell Death
in the Brain
Several recent studies have indicated that reduction of
oxidative stress may protect the developing animal from
anesthetic-induced brain cell death. Thus, continuous exposure
of developing brains to ketamine causes selective cell death by
a mechanism that involves a compensatory upregulation of
NMDA receptor subunits (Wang et al., 2005, 2006). This
upregulation makes neurons bearing these receptors more
vulnerable, after ketamine washout, to the excitotoxic effects of
endogenous glutamate. In fact, this hypothesis was supported
by the observation that the NR1 subunit mRNA was
upregulated in ketamine-treated monkey fetuses (gestation
day 122) and infants (post natal day 5) compared with their
controls, and increased expression of NMDA receptor NR1
protein in ketamine-treated neurons (in vitro monkey). In
addition, coadministration of NR1 antisense oligonucleotide
(targeted to NR1 NMDA receptor subunit mRNA) is able to
block the neuronal cell death induced by ketamine in rat and
monkey cortical culture (Wang and Slikker, 2008). Associated
with Ca2þ inﬂux is an increase in ROS that appears to
originate in the mitochondria (Johnson et al., 1998; Slikker
et al., 2005). This Ca2þ loading by the mitochondria beyond
its buffering capacity reduces the membrane potential and
disrupts electron transport, which results in the increased
production of the reactive free radical superoxide anion [O 
 2]
(Slikker et al., 2005, 2007; Wang et al., 2000). Meanwhile, the
increased intracellular free calcium [Ca2þ] is a potent activator
of neuronal nitric oxide synthase (nNOS). Active nNOS
generates NO, a multifaceted second messenger, which
permeates neuronal cell membranes to alter speciﬁc tissue
regions. Therefore, a signiﬁcant issue to be resolved is whether
increased neuronal NOS activity and increased generation of
peroxynitrite are key regulatory steps in the apoptotic process
induced by the administration of NMDA antagonists such as
ketamine.
In experiments with cultured newborn rat forebrain cells,
ketamine caused an increase in DNA fragmentation, elevated
immunoreactivity to nitrotyrosine, a marked reduction in the
expression of neuronal marker polysialic acid neural cell
adhesion molecule and a reduction in mitochondrial metabo-
lism. Among the potential downstream regulators, the ratio of
Bax and BCL-XL was determined. Bax, a proapoptotic protein,
is a pore-forming cytoplasmic protein which translocates to the
outer mitochondrial membrane, inﬂuencing its permeability
and inducing cytochrome c release from the intermembrane
space of the mitochondria into the cytosol, subsequently
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the BCL-XL/Bax ratio is associated with apoptosis as was
seen with ketamine. Interestingly, all these ketamine-
induced neurotoxic effects were blocked by 7-Nitroindazole,
an NOS inhibitor. Overall, these data suggest a role for NRS
as mediated by NO in enhanced degeneration induced by
ketamine in vitro and that blockage of nNOS may be beneﬁcial
for reducing the risk of pediatric use of ketamine (Wang et al.,
2008). Further evidence for the role of oxidative stress in
anesthetic-induced neurotoxicity has been generated in studies
that apply oxidative stress blockers including L-carnitine
(mitochondrial protector) and melatonin in vivo (Yon et al.,
2006) and speciﬁc antioxidants in vitro including the
superoxide dismutase mimetic as described above, M40403
and the NOS inhibitor, 7-nitroindazole.
The hypothesis that oxidative stress is associated with
anesthetic-induced brain cell death is also supported by data
generated by studies on the catalase pathway. Although the
precise mechanisms by which NMDA regulates neuroapoptosis
is unknown, blockade of this activity in vitro by the addition of
catalase and superoxide dismutase (Wang et al., 2000), or
in vivo by M40403 (superoxide dismutase mimetic) supports
the involvement of ROS. Further evidence for the role of
oxidative stress in anesthetic-induced neurotoxicity has been
generated in studies that apply oxidative stress blockers
including L-carnitine (mitochondrial protector) and melatonin
in vivo and speciﬁc antioxidants in vitro including the
superoxide dismutase mimetic as described above, M40403
and the NOS inhibitor, 7-nitroindazole. Recent gene expression
assessments indicate that genes along the oxidative stress
pathway are altered by a single, high dose ketamine treatment
of the developing rat (Slikker et al., 2007). Together, the
application of omics approaches along with traditional
toxicological endpoints suggests that the susceptibility of the
developing brain to anesthetics is mediated by oxidative stress.
Antioxidants Attenuate the Induction of
Anesthetic-Induced Cell Death
The conclusion that the susceptibility of the developing brain
to anesthetics is mediated by oxidative stress is further
supported by studies on the anesthetic gas nitrous oxide
(N2O) and the volatile anesthetic isoﬂurane (ISO). Both are
commonly utilized in surgical procedures for human infants
and in veterinary and laboratory animal practice to produce the
salubrious properties such as loss of consciousness and
analgesia. Recent reports indicate that exposure of the
developing brain to general anesthetics that block NMDA
glutamate receptors or potentiate gamma aminobutyric acid(A)
receptors can trigger widespread apoptotic neurodegeneration
(Jevtovic-Todorovic et al., 2003). A subsequent publication
indicated that melatonin, an antioxidant, attenuated the effects
produced by these anesthetic agents in the developing rat pup
(Yon et al., 2006). Two main questions remain: what are the
effects of equi-anesthetic levels of N2O and ISO alone or in
combination and can a mitochondrial protector such as L-
carnitine attenuate these effects?
In postnatal day 7 pups, no signiﬁcant neurotoxic effects
were observed in animals exposed to N2O or ISO alone.
However, enhanced apoptotic cell death was apparent when
N2O was combined with ISO, at exposure durations of 6 hours
or more. Coadministration of L-carnitine protected neurons
from inhaled anesthetic-induced damage. These data indicate
that 6 h or more of inhaled anesthetic exposure results in
enhanced neuronal apoptosis in developing rat brain and
that L-carnitine effectively blocks this neuronal apoptosis.
These data also indicate that the in vivo application of the
mitochondrial protector L-carnitine may provide a strategy for
clinical neuroprotection (Zou et al., 2009).
In summary, the data presented suggest that anesthetic
exposure can cause apoptosis in the developing brain (Fig. 3).
Although several mechanisms are proposed, upregulation of
the NR1 subunit of the NMDA receptor appears to be an
important ﬁrst step in the pathway to anesthetic-induced
neurotoxicity. Subsequently, excitotoxic effects of glutamate
are largely mediated by increased Ca2þ inﬂux through
activated NMDA receptors. Associated with Ca
2þ inﬂux is
an increase in the generation of ROS that appears to originate
in mitochondria. This leads to dissociation and nuclear
translocation of transcription factors such as NF-jB ultimately
resulting in downregulation of Bcl-XL combined with an
FIG. 3. A working model of NMDA antagonist-induced neuronal cell
death. Excessive activation of upregulated NMDA receptors results in a calcium
overload that exceeds the buffering capacity of the mitochondria and interferes
with electron transport yielding ROS. This in turn causes dissociation and
nuclear translocation of transcription proteins such as NF-jB that bind to genes
such as P53 and Bcl-XL. The downregulation of Bcl-XL combined with an
increase in Bax, diminishes the formation of antiapoptotic Bax/Bcl-XL
heterodimers in favor of proapoptotic Bax/Bax homodimers.
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mechanisms. Understanding these toxicity pathways allows
postulation of protective approaches and their systematic
assessment. Several recent studies using blockers of oxidative
stress such as L-carnitine, melatonin, the superoxide dismutase
mimetic, M40403, and the NOS inhibitor, 7-nitroindazole have
indicated that reduction of oxidative stress may protect the
developing animal from anesthetic-induced brain cell death.
MACROPHAGES, OXIDATIVE STRESS, AND LUNG
INJURY
In addition to being implicated in brain injury, considerable
evidence supports a role for reactive oxygen and RNS in lung
injury induced by pulmonary irritants. These and other
inﬂammatory mediators are released by phagocytic leukocytes
and inﬁltrating macrophages in the lung (Benoit et al., 2008;
Laskin and Laskin, 2001; Laskin et al., 2001; Libby,
2007). Of particular interest is the role of ROS and RNS in
the toxicity of ozone, a ubiquitous urban air pollutant known to
cause oxidative damage to the lower lung (Mudway and
Kelly, 2000). Following ozone inhalation by rodents, alveolar
macrophages are activated to generate excessive quantities of
NO and peroxynitrite (Fakhrzadeh et al., 2002, 2004a, b, 2008;
Pendino, et al., 1993, 1995, 1996) (Fig. 4). Moreover,
inhibiting the activity of macrophages or production of these
RNS abrogates ozone-induced tissue injury (Fakhrzadeh et al.,
2002, 2004a, b; Pendino et al., 1995). These data provide direct
support for the idea that macrophages and inﬂammatory
mediators such as RNS can contribute to tissue damage.
Production of RNS in the Lung after Ozone Inhalation
There are several mechanisms proposed to explain the
regulation of excessive production of RNS by macrophages in
the lung after ozone inhalation. NO is produced in macro-
phages via an inducible form of the enzyme, NO synthase
(iNOS or NOS2). This enzyme is upregulated by inﬂammatory
mediators such as bacterially derived lipopolysaccharide (LPS),
and cytokines like tumor necrosis factor alpha (TNF-a). TNF-a
exerts its biological activity by binding to a receptor on
macrophages; 2 major receptors have been identiﬁed: TNFR1
(p55) and TNFR2 (p75). Evidence suggests that the proin-
ﬂammatory actions of TNF-a are mediated predominantly via
activation of TNFR1. This receptor is localized in both lipid
raft and non-raft regions of the plasma membrane. In response
to TNF-a, TNFR1 rapidly associates with lipid rafts where it
complexes with TNF-a (Doan et al., 2004). This leads to the
recruitment of adaptor proteins and activation of a cascade of
signaling molecules including phosphatidylinositol 3 (PI 3)-
kinase, p44/42 MAP kinase, and consequent activation of
NF-jB, a transcription factor important in the regulation of
many inﬂammatory genes including iNOS (Aggarwal et al.,
2002).
Following ozone inhalation, there is a rapid and persistent
activation of NF-jB in alveolar macrophages. This is associated
with a rapid induction of PI 3-kinase and its downstream target,
protein kinase B (PKB). These data, together with the
observation that inhibitors of PI 3-kinase block excessive NO
production by alveolar macrophages from ozone treated mice
suggest that NF-jB and upstream regulators PI 3-kinase and
PKB are important in controlling expression of iNOS. This is
supported by ﬁndings that ozone-induced increases in NF-jB
nuclear binding activity are signiﬁcantly attenuated in NF-jB
p50 /  (knockout) transgenic mice (Fakhrzadeh et al., 2004b).
Additionally, the loss of NF-jB p50 is associated with a marked
reduction in ozone-induced upregulation of iNOS and an
abrogation of NO or peroxynitrite generation by macrophages.
Moreover, mice lacking NF-jB p50 were protected against
ozone-induced toxicity. Taken together, these data demonstrate
thatozone-inducedexpressionofiNOSandNOproductioninthe
lung are dependent on NF-jB.
Ozone and Lung Toxicity: Role of TNF-a
Asdescribedabove,TNF-aisknowntobeamajoractivatorof
NF-jB signaling. Treatment of mice with ozone resulted in
increased expression of TNF-a in the lung (Fakhrzadeh et al.,
2004b; Pendino et al., 1994). Using knockout mice with
a targeted deletion of the gene for TNF-a, the role of this
cytokine in ozone-induced NF-jB activation and iNOS in-
ductionwasinvestigated.OzonehadnoeffectonNF-jBactivity
oroniNOSinductioninTNF-aknockoutmice.Thefactthatthis
was associated with protection from ozone toxicitysuggests that
TNF-a produced early after ozone inhalation contributes to
tissue injury, in part, by stimulating the production of cytotoxic
inﬂammatory mediators such as NO and peroxynitrite via
activation of NF-jB.
Caveolae and TNF-a–Mediated Lung Responses
Caveolae are small (50–100 nm) vesicular invaginations of
the plasma membrane. Because of their unique lipid
FIG. 4. Exposure to toxic levels of ozone results in alveolar epithelial
damage. Macrophages responding to tissue injury release TNF-a which
downregulates caveolin-1. This leads to release of signaling molecules such as
PI3K, activation of NF-jB and upregulation of iNOS. RNS generated as
a consequence contribute to ozone-induced lung injury.
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rafts. The chief structural proteins of caveolae are caveolins. To
date, 3 caveolins (Cav-1, Cav-2, and Cav-3) with unique tissue
distribution have been characterized. Cav-1 is a 21- to 24-kDa
protein that has been identiﬁed as the main structural and
functional protein of caveolae, required for their formation and
stabilization. Cav-1 functions as a membrane-organizing
center, concentrating signaling molecules within a scaffolding
domain and negatively regulating their activation state (Hnasko
and Lisanti, 2003). Functional caveolin-binding motifs have
been identiﬁed in a number of signaling molecules including
TNFR1, in several serine/threonine kinases (p44/42 MAP
kinases, PI 3-kinase) and tyrosine kinases (src kinase), as well
as in endothelial NO synthase, and heme oxygenase-1
(Williams and Lisanti, 2004). Downregulation of Cav-1 leads
to activation of these signaling pathways.
Alveolar macrophages from control animals constitutively
express Cav-1 protein (Fakhrzadeh et al., 2008). Treatment of
mice with ozone caused an immediate decrease in Cav-1
expression that began to return to control at 12 h. The
suppressive effects of ozone on Cav-1 expression were not
observed in TNFR1 /  mice demonstrating that ozone-
induced alterations in Cav-1 are dependent on TNF-a signaling
via this receptor. This conclusion is supported by the
observation that TNF-a was effective in suppressing Cav-1
expression in macrophages in culture.
Insummary,thedatasupportamodelwhereexposuretotoxic
levelsof ozoneresultsininjuryto Type Ialveolarepithelial cells
in the lower lung and the release TNF-a by alveolar macro-
phages. Consequently, TNFR1 signaling via TNFR1 down-
regulates Cav-1 in macrophages leading to activation of
signaling pathways like PI-3 kinase/PKB, subsequent activation
NF-kB, upregulation of iNOS, and excessive production of
reactive oxygen and nitrogen species. Understanding processes
of ozone-induced tissue injury is critical for the development of
clinical approaches for treating or abrogating toxicity induced
not only by air pollutants, but also potentially, by chronic and
episodic inﬂammatory lung diseases.
THE ROLE OF NITRATIVE AND OXIDATIVE STRESS IN
SEPSIS
So far, we have considered basic mechanisms of oxidative
and nitrative stress as illustrated by exposure of the developing
brain and the lungs to anesthetics and ozone, respectively.
Now, we consider the role of ROS and RNS in sepsis and
preterm labor. Sepsis is a major challenge to health care in the
United States, affecting about 750,000 people, causing about
215,000 deaths, and costing nearly $17 billion annually (Zhao
et al., 2006). Oxidants, radicals, ROS, and oxidant stress
mechanisms have been implicated in septic shock, but the
mechanisms underlying their effects have not been deﬁned
with the speciﬁcity that will be essential in developing
approaches to the prevention and treatment of this complex
medical condition.
Inﬂammation and Premature Labor
In the United States, 12.7% of infants born in 2005 were
delivered at less than 37 weeks gestational age, which
represents a 34% increase from the rate of 9.5% reported
in 1981. The annual economic cost of preterm labor and birth
to the United States was estimated to be at least $26 billion
(Behrman and Butler, 2006; Goldenberg et al., 2008;
Shepherd et al., 2004; Zhao et al., 2006), and preterm
delivery is associated with about half of long-term morbidities
arising in newborns. Worldwide, an estimated 4 million
deaths occur each year in neonates (less than 4 weeks of age),
and 28% of these deaths are attributed to preterm birth as
the primary cause (Lawn et al., 2005). In addition, an
estimated 4 million infants are stillborn each year. The cause
and effect mechanisms that contribute to inﬂammatory
responses in preterm birth, stillbirth, and sepsis thus merit
more research interest than has been directed at these
problems to date.
Mechanisms of Preterm Birth
Chorioamnionitis, gingivitis, bacterial vaginosis, and other
maternal infections have been implicated as major causal
factors in premature births (Goldenberg et al., 2000), usually
deﬁned as births at less than 37 weeks gestational age. Despite
the associations between maternal infections and preterm birth,
prophylactic administration of antibiotics to pregnant women,
even those in spontaneous preterm labor with intact mem-
branes, has shown no efﬁcacy for preventing preterm births
(Kenyon et al., 2008). Further, adverse effects of antibiotic
treatments have been observed, including increased incidence
of cerebral palsy. Animal models of premature birth have
shown that preterm delivery and intrauterine fetal death can be
produced by administration of live pathogens or by puriﬁed
bacterial products, such as LPS or lipoteichoic acid (Fidel
et al., 1998; Kajikawa et al., 1998). The induction of preterm
labor and of fetal demise by administration of killed bacteria or
even puriﬁed bacterial components suggests an explanation as
to why antibiotic treatments are not effective in preventing
preterm birth. In addition, the observations of increased rates of
fetal death in these experimental models suggest close
mechanistic links between stillbirth and preterm birth in
humans.
In both pregnant and nonpregnant experimental animals,
administration of bacteria, or bacterial products initiates marked
increases in cytokine levels, but the broad and overlapping
responses in individual cytokines serves to obscure any critical
mechanistic pathways that might exist. So, do oxidative
mechanisms contribute to preterm delivery and fetal death?
When LPS was administered to pregnant mice, decreases in
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(Buhimschi et al., 2003). It was also reported that the effects of
LPS on acceleration of delivery, fetal death, and hepatic GSH
levels were attenuated by administration of N-acetylcysteine
(NAC). The authors interpreted their data as indicating that free
radicals generated in large quantities in response to LPS
administration were shifting the maternal–fetal redox balance to
an oxidative state, resulting in the observed fetal death and
preterm delivery. These studies provide a useful ﬁrst step in
investigation of possible contributions of biochemical mecha-
nisms to infection and preterm birth.
Oxidative Stress, Preterm Birth, and Fetal Death
In the report by Buhimschi, decreases in hepatic GSH were
observed only at 16 h post LPS treatment (Buhimschi et al.,
2003), whereas no differences in GSH were observed in fetuses
or dams at 3 or 6 h. None of the fetuses examined 3 or 6 h after
administration of LPS were dead, but over half of all the
fetuses were dead by 16 h. The median time to onset of
delivery in LPS-treated mice was 16.8 h, and all fetuses
delivered were dead. Causes must precede effects, and
breakdown of the compartmentalization of oxidants and
reductants on which cell functions rely would be expected to
arise during damage and/or death of aerobic cells and result in
increased oxidations of biological molecules. Hence, the
distinctions between cause and effect for hepatic GSH
depletion, fetal demise, and preterm delivery are speculative
at the moment, however logical and appealing the working
hypothesis.
ROS Involved in Sepsis
Sepsis occurs as a result of complex host-pathogen
interactions, leading to release of inﬂammatory mediators, as
well as reactive oxygen intermediates (ROS) and reactive
nitrogen intermediates (RNS). Neutrophils and monocyte/
macrophages are the sentinel phagocytic cell primarily re-
sponsible for engulfment and destruction of pathogenic
organisms during infection of the host. ROS and RNS are
antimicrobial agents produced by these leukocytes that can
directly destroy microbial pathogens. During sepsis, excess
production of ROS and RNS can be a detriment, inducing
signiﬁcant cytotoxicity to organs and contributing to the
sequelae of unresolved sepsis, multiorgan system failure
(Fialkow et al., 2007).
The inﬂammatory mediators best characterized as having
a role in sepsis are Interleukin-1 (IL-1), tumor necrosis factor
(TNF), and IL-6. Very recent studies have identiﬁed a new
sepsis-related cytokine, Interleukin-27, as a member of the
IL-6/IL-12 cytokine family that is a negative regulator of innate
immunity during sepsis (Wirtz et al., 2006).
These inﬂammatory mediators, as well as ROS and RNS
induce cytotoxicity leading to damage to multiple organs, and
without resolution of these activities may ultimately result in
multisystem organ failure. ROS and RNS are known to directly
induce cytotoxicity to organs and can also alter cell signaling
pathways.
Interestingly the source of ROS may be a key to the extent of
cellular cytotoxicity that occurs during sepsis and may also be
involved in the ultimate ability of the host to limit sepsis. A
very recent study reported that ROS derived from NADPH
oxidase limited acute inﬂammatory responses in vivo induced
by LPS administration, suggesting that the ROS derived from
this enzyme source may limit the extent of cytotoxicity and
alterations in oxidation reduction reactions such as changes in
GSH during sepsis (Zhang et al., 2009). During LPS-induced
endotoxemia, ROS was found to be signiﬁcantly increased and
was shown to limit the availability of NO, resulting in LPS-
induced endothelial dysfunction, with the primary source of
ROS identiﬁed as cyclooxygenase-2 (Cox-2) (Virdis et al.,
2005).
Studies within the last 5 years have identiﬁed a defect in
neutrophil function of neonates that may be associated with
the predisposition of preterm neonates to bacterial infection.
In adults, neutrophils, and mast cells form extracellular traps
(ETs) composed of extracellular DNA, chromatin, histones,
and antibacterial peptides, proteolytic enzymes that destroy
microbes. This phagocytic activity of neutrophils that have
produced ETs results in induction of a speciﬁc death pathway
deﬁned as ‘‘Etosis’’ which these neutrophils. Etosis is
mediated through ROS generated through the NADPH
oxidase enzyme pathway (Wartha and Henriques-Normark,
2008). In preterm infants, neutrophils have an impaired
formation of ETs which is associated with the lack of
microbiocidal activity of neutrophils from preterm neonates
and was not found to be linked to the presence of ROS. These
defects in linked pathways in preterm infants are thought to be
a common immunodeﬁciency in the lack of response of
preterm neonates to respond to microbial challenge (Yost
et al., 2009).
In summary, the lives lost and the social and economic
costs of preterm birth and stillbirth are enormous in the
United States and throughout the world. Maternal infections
are associated with and likely responsible for a large fraction
of these problems, but prevention of all exposures of
pregnant women to bacteria or other potential pathogens is
impractical and possibly even undesirable. Treatments of
clinically signiﬁcant infections in women clearly are
essential, deﬁning the more complex mechanisms relating
maternal infections with stillbirths, preterm births, and other
adverse effects on fetal health and development is essential
for the rational design and investigation of approaches to
amelioration of these underappreciated problems in human
health. Much can be learned both from further study of
this area and also from basic mechanistic work on oxidative
and nitrative stress in other organ systems such as lung, brain
and gut.
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PHENOTYPE OF INFLAMMATORY BREAST CANCER
It is clear that oxidative and nitrative stress play a role in the
response to toxicants and in proinﬂammatory conditions such as
sepsis. The data presented above make a case for a role for the
inﬂammatory response to bacteria in preterm birth and fetal
death. Now we move on to consider the role oxidative stress
plays in the development of diseases such as cancer, in
particular, inﬂammatory breast cancer (IBC). IBC is the most
aggressive and lethal form of breast cancer and has the worst
prognosis of any variant of this disease (reviewed in Dawood
etal.,2008).IBCtumorsdonotcommonlypresentasalumpbut
are rather diffuse, requiring imaging modalities such as
magnetic resonance imaging (MRI) and positron emission
tomography (PET) for accurate diagnosis and tumor staging.
IBC commonly presents as a skin rash due to inﬁltration of IBC
tumor cells into dermal lymphatics, leading to common
misdiagnosis of this type of breast cancer as mastitis and
treatment of IBC patients with antibiotics, delaying correct
diagnosis. IBC patients often have lymph node involvement,
with late stage disease (stage IIIb or stage IV) at the time of ﬁrst
accurate diagnosis. Although the standard of care for IBC
patients for the past 30 years has been multimodality treatment
combining chemotherapy, surgery, and radiation, there has been
no change in the very low survival rate of 2.9 years for patients
diagnosed with IBC during this time (Ueno et al., 1997).
IBC and the Role of NF-jB and Inﬂammatory Mediators
Based on studies evaluating IBC tumors, an inﬂammatory
signature has been deﬁned suggesting that IBC is characterized
bytheinvolvementofgenesregulated bythetranscriptionfactor
NF-jB (Charafe-Jauffret et al., 2004). Thus, there is a common
mechanism of signaling with the brain and lung injury described
above but there are stark contrasts in the availability of model
systems to study IBC because there are only 2 cell lines
available, the SUM190 and SUM149 cell lines with which to
study this disease. The SUM190 cell line was developed from
the primary tumor of an IBC patient and the SUM149 cells were
derived from metastatic tumor cells isolated from pleural
effusion ﬂuid of an IBC patient (Ethier, 1996).
In order to understand basic mechanisms and to deﬁne
potential therapeutic targets, real time PCR arrays were used in
combination with Western blotting to elucidate IBC-related
genes involved in oxidative and nitrative stress and associated
inﬂammation. Both SUM149 and SUM190 IBC breast tumor
cells express levels of the PTGS-2 gene that are 2500 and
11,000-fold increased, respectively, compared with the PTGS-
2 null MCF-7 breast cancer cell line (Fig. 5A). PTGS-2
encodes for the inducible form of Cox-2, the enzyme
responsible for production of the proinﬂammatory mediator,
prostaglandin E2 (PGE2). Although previous studies have
demonstrated that Cox-2 is highly elevated in IBC tumors
(Charafe-Jauffret et al., 2004), the loss of selective Cox-2
inhibitors had lead the way in the search for alternative
approaches to block Cox-2 driven inﬂammatory responses in
this very aggressive form of breast cancer. EP4 appears to be
one of the critical prostanoid receptors that may well serve as
a target for Cox-2 associated therapeutics in breast cancer
progression (Robertson et al., 2008).
As a validation of the increased Cox-2 mRNA, we evaluated
the levels of PGE2 production and Cox-2 protein produced by
SUM149 and SUM190 (Figs. 5B and 5C). Both of these cell
lines secrete elevated amounts of PGE2, which were increased
with addition of the substrate for the Cox-2 enzyme,
arachidonic acid (Fig. 5B). Both of the IBC cell lines also
produced abundant Cox-2 protein (Fig. 5C). The importance of
Cox-2 as a critical regulator of breast tumor proliferation,
angiogenesis and invasion was demonstrated by previous
studies showing that Cox-2 directly regulates these activities
of breast tumor cells, in breast tumors and in breast
tumor xenografts in immunocompromised mice (Parrett
et al., 1997; Prosperi et al., 2004; Prosperi and Robertson,
2006).
To date, there have been no studies that have reported what
ROS are generated in IBC tumors. There have been multiple
studies documenting that IBC tumor cells produce abundant
levels of inﬂammatory cytokines such as Interleukin-1 alpha
and beta, Interleukin-8, Interleukin-8 and chemokines such as
GRO and Rantes (Benoy et al., 2004; Pan et al., 2003; van
Golen et al., 2000). Although some studies identiﬁed both
Cox-2 and Nfjb transcription factor as being highly upregu-
lated in IBC cell lines (Robertson et al., 2008; Van Laere et al.,
2006) there been no studies that have evaluated these
aggressive breast tumor types for the presence of oxidized
products of arachidonic acid metabolism as a unique signature
of ROS derived from oxidized products.
IBC, Inﬂammation, and Therapeutic Opportunities
Although numerous studies have now reported that selective
Cox-2 inhibitors have antitumor and antiangiogenesis activities
and effectively block breast cancer progression, use of these
agents has cardiovascular risks stimulating the search for other
approaches to block Cox-2/PGE2 associated activities. One
alternative is to inhibit the binding of PGE2 to its G protein
coupled receptors, deﬁned as the prostanoid receptors (EPs).
There are 4 members of this receptor family, designated as
EP1, EP2, EP3, and EP4. Although EP1 and EP2 appear to
have roles in regulating the hyperplasia at early stages of tumor
development, the EP4 receptor is more likely involved in
regulation of breast tumor cell invasion and metastasis through
its ability to block the effects of PGE2 following receptor-
ligand binding (Robertson et al., 2008). IBC tumor cells with
high Cox-2 expression also express high levels of EP4 receptor
(Fig. 5C). Neither antagonists of the EP1 or EP2 prostanoid
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as a downregulatory receptor, had any signiﬁcant effect on
biological activities of IBC tumor cells. In contrast, both the
EP4 chemical antagonist GW 627368X and SUM149 stable
clones containing EP4 speciﬁc short hairpin RNAi inhibited
anchorage independent growth in soft agar (Fig. 5D). Because
anchorage independent growth in soft agar is used as a gold
standard to determine the effect of agents on in vivo
tumorigenesis, these studies suggested it would be important
to evaluate the effect of EP4 blockade in vivo. Key next steps
are to evaluate the effects of targeting EP4 using pharmaco-
logical and molecular strategies that block Cox-2 driven
invasion, angiogenesis and metastasis in IBC xenografts.
In summary, it is clear that oxidative stress is key in the
development of diseases such as IBC mediated via activation of
transcription factors such as NF-jB and induction of a proin-
ﬂammatory environment. There are key mediators such as
Cox-2 and PGEs and the present observations demonstrate that
targeting molecules associated with the Cox-2/PGE2/EP4
receptor pathways may be useful as probes to deﬁne the
speciﬁc role of Cox-2 and PGE2 in IBC and potentially may
serve as targets for development of effective IBC-speciﬁc
therapeutics to inhibit the aggressive phenotype of this lethal
variant of breast cancer.
GENERATION OF REACTIVE INTERMEDIATES DURING
DOPAMINE CATABOLISM: IMPLICATIONS FOR
PARKINSON’S DISEASE
As described for IBC, knowledge of the inﬂammatory
mediators provides opportunities to target these pathways in
a rational plan of treatment. This is also well illustrated when
we consider Parkinson’s disease (PD). PD is one of the most
FIG. 5. Elucidation of IBC-related genes involved in oxidative and nitrative stress and associated inﬂammation. (A) PTGHS2/COX-2 mRNA is upregulated in
SUM149 and SUM190 IBC cells compared with MCF-7 cells. (B) PGE2 production by SUM149 and SUM190 cells. (C) Western blot of COX-2 and EP4
proteins in SUM149 and SUM190 IBC tumor cells. (D) Inhibition of anchorage independent growth in soft agar by SUM149 IBC cells by EP4 antagonist and EP4
shRNA.
12 ROBERTS ET AL.common neurodegenerative diseases in the United States and is
characterized by the loss of dopamine (DA) neurons. This
neuronal loss translates into symptoms of motor dysfunction
observable as asymmetric rigidity, tremors, bradykinesia, and
postural instability. Several factors have been implicated in the
pathogenesis of PD, including environmental toxicants, in-
ﬂammation, and oxidative stress (Jenner, 2003).
In regards to environmental toxicants, a number of pesti-
cides have been correlated to PD etiology, particularly the
organochlorine, dieldrin (Kanthasamy et al., 2005). Elevated
levels of this compound have been found in the post-mortem
brains of PD patients, implicating a link between pesticide
exposure and PD (Corrigan et al., 2000).
PD, Pesticides, and Oxidative Stress
Previous work has demonstrated the ability of dieldrin to
generate oxidative stress in cellular models of PD (Kanthasamy
et al., 2005). This was observed as an increase in the ROS
superoxide anion, and the production of this ROS was
preventable with the pretreatment of superoxide dismutase,
the enzyme responsible for the conversion of superoxide anion
to hydrogen peroxide. Dieldrin also disrupts a number of other
cellular processes related to PD such as mitochondrial function,
lipid peroxidation, and induces apoptosis (Kanthasamy et al.,
2005). Current research efforts in this area include elucidating
the structure–activity relationship of dieldrin in reference to the
numerous adverse cellular effects it initiates, as well as
determining speciﬁc cellular targets that may explain the
disruptions in cellular function and generation of oxidative
stress.
The mechanism by which oxidative stress translates into
selective degeneration of DA neurons is unknown. Two
biomarkers of oxidative stress are the lipid peroxidation
products 4-hydroxynonenal (4HNE) and malondialdehyde
(MDA) (Esterbauer et al., 1991). Lipid peroxidation products
(i.e., 4HNE) were found to be elevated in PD patients (Yoritaka
et al., 1996), and recently, were linked to impairments in DA
catabolism (Rees et al., 2007).
DA is Both a Neurotransmitter and a Neurotoxicant
DA is an important neurotransmitter; however, it is also
neurotoxic given its catechol group, which has the propensity
to redox cycle and generate ROS (superoxide anion) in the
presence of molecular oxygen (Fig. 6). Also, of note, the auto-
oxidation of this compound yields a highly Cys-reactive ortho-
quinone that readily modiﬁes proteins. DA undergoes metabolism
initially by monoamine oxidase (MAO) yielding the toxic and
protein-reactive intermediate 3,4-dihydroxyphenylacetaldehyde
(DOPAL), which is further oxidized to 3,4-dihydroxyphenylacetic
acid (DOPAC) via aldehyde dehydrogenase (ALDH) or reduced
to 3,4-dihydroxyphenylethanol (DOPET) via reductases. An
outline of this catabolism (Fig. 5) illustrates that there may be
multiple ALDH (e.g., mitochondrial ALDH known as ALDH2)
and cytosolic AR enzymes participating in metabolism of the DA-
derived aldehyde.
Oxidative Stress and DA Catabolism
Previous work has demonstrated the enzyme ALDH to be
highly sensitive to products of oxidative stress (Florang et al.,
2007; Jinsmaa et al., 2009; Rees et al., 2007). Using models for
DA metabolism such as rat brain mitochondria, rat striatal
synaptosomes and PC6-3 cells, both 4HNE and MDA were
found to disrupt DA catabolism via potent inhibition of ALDH
but not MAO at physiologic concentrations, yielding a several-
fold increase in the level of cellular DOPAL. Reductases can
compensate for impaired ALDH activity, and indeed, treatment
FIG. 6. Schematic of DA catabolism. DA catabolism yields DOPAL, which undergoes oxidation to an acid (DOPAC) or reduction to an alcohol (DOPET) as
a minor pathway. Increased cytosolic DA or impairment of aldehyde metabolism yields elevated levels of the reactive and toxic intermediate, DOPAL.
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increase in (DOPAL) but also (DOPET), compared with
control. Surprisingly, however, MDA but not 4HNE was
shown to inhibit reductase-mediated metabolism of DOPAL at
low lM concentrations. The impaired DA catabolism via lipid
peroxidation products was found to yield elevated levels of
DOPAL–protein adducts.
Of concern for the elevated concentration of DOPAL is that
this DA-derived aldehyde was found to be highly toxic to
dopaminergic cells and hypothesized to be a ‘‘chemical
trigger’’ relevant to neurodegeneration such as PD (Burke,
2003; Burke et al., 2004). Previous studies reported DOPAL to
be much more toxic to dopaminergic cells compared with DA,
that is, 100-fold more in vitro and 1000-fold greater in vivo.
The mechanism for DOPAL-mediated cytotoxicity may in-
volve the following: protein modiﬁcation, generation of the
hydroxyl radical, or mitochondrial pore transition. With respect
to protein modiﬁcation, elevation of [DOPAL] was correlated
with increased catechol–protein adducts (Rees et al., 2007).
Because DOPAL contains both a catechol and aldehyde,
protein reactivity is predicted to result from interaction of
amines (e.g., Lys) with the aldehyde or thiols (i.e., Cys) with
the oxidized catechol (i.e., ortho-quinone); however, the DA-
derived aldehyde may also be a bifunctional electrophile
capable of cross-linking proteins (Rees et al., in press). In
support of such a hypothesis, a recent paper reported DOPAL-
mediated cross-linking of a-synuclein, a protein found to
aggregate in the PD brain (Burke et al., 2008).
In summary, there are much data demonstrating the
sensitivity of DA catabolism to products of oxidative stress
and such work implicates a mechanistic link between oxidative
stress and elevated levels of DOPAL, a neurotoxin endoge-
nous to DA neurons hypothesized to be a factor in neuro-
degeneration (Fig. 5). Current and future studies seek to deﬁne
the pathway by which DOPAL interacts with proteins,
elucidate other mechanisms for generation of the DA-derived
aldehyde at aberrant levels and deﬁne the link between
DOPAL and PD-relevant neurodegeneration. Such work has
signiﬁcant implications for development of therapeutics as
DOPAL or other disease-relevant carbonyls may represent
a therapeutic target such as carbonyl scavengers that prevent
protein modiﬁcation and/or cross-linking (Burcham and Pyke,
2006). In addition, this research may yield biomarkers for
early disease diagnosis.
CONCLUSIONS
It is clear from the examples presented that oxidative and
nitrative stress play a pivotal role in disease pathogenesis and in
tissue damage in response to toxicant exposures. Inﬂammation
andsubsequentadaptationorcelldeatharecommonfeaturesand
several signaling pathways are implicated in these processes.
Clearly, TNF-a and subsequent abrogation of associated
downstream signaling via survival networks such as that
mediated by NF-jB are central in most if not all of the tissues
considered. Additionally, there is evidence to support an
interaction between oxidative and nitrative species, mitochon-
drial signaling and the caspase cascade. Conversely, certain
routes of investigation such as the role of caveolae have only
been explored in some model systems and pathological
conditions such as the response of the lung to ozone; this
suggests that this could be an interesting and fruitful route of
investigation for other problems such as IBC, sepsis, and PD.
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